InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) announced that a new patient has been enrolled into The INSPIRE Study (InVivo Study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE